$LPCN
Lipocine Inc.

2016 Q2 Form 10-Q Financial Statement

#000114420416099991 Filed on May 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q1
Revenue $3.100K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.250M $4.400M $1.060M
YoY Change 190.18% 315.09% -44.79%
% of Gross Profit
Research & Development $2.570M $2.673M $1.919M
YoY Change -18.72% 39.33% -43.05%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $0.00
YoY Change 0.0%
% of Gross Profit
Operating Expenses $5.820M $7.070M $2.974M
YoY Change 36.05% 137.72% -43.8%
Operating Profit -$5.815M -$7.070M -$2.974M
YoY Change 35.94% 137.72% -43.8%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $60.00K $60.00K $20.00K
YoY Change 100.0% 200.0% -33.33%
Pretax Income -$5.760M -$7.009M -$2.956M
YoY Change 35.64% 137.13% -43.89%
Income Tax $0.00 $700.00 $200.00
% Of Pretax Income
Net Earnings -$5.760M -$7.009M -$2.956M
YoY Change 35.65% 137.14% -43.88%
Net Earnings / Revenue -185810.03%
Basic Earnings Per Share -$0.32 -$0.38 -$0.23
Diluted Earnings Per Share -$0.32 -$0.38 -$0.23
COMMON SHARES
Basic Shares Outstanding 18.26M shares 18.25M shares 12.82M shares
Diluted Shares Outstanding 18.25M shares 12.82M shares

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.94M $38.21M $24.76M
YoY Change -24.91% 54.32% -40.72%
Cash & Equivalents $12.37M $14.11M $24.76M
Short-Term Investments $20.57M $24.10M
Other Short-Term Assets $150.0K $270.0K $190.0K
YoY Change -16.67% 42.11% -26.92%
Inventory
Prepaid Expenses
Receivables $100.0K $160.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $33.20M $38.64M $24.95M
YoY Change -24.8% 54.87% -40.64%
LONG-TERM ASSETS
Property, Plant & Equipment $120.0K $110.0K $80.00K
YoY Change 50.26% 37.5% 189.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0%
Other Assets $30.00K $20.00K $20.00K
YoY Change 26.3% 0.0% -55.56%
Total Long-Term Assets $150.0K $130.0K $110.0K
YoY Change -98.45% 18.18% 51.45%
TOTAL ASSETS
Total Short-Term Assets $33.20M $38.64M $24.95M
Total Long-Term Assets $150.0K $130.0K $110.0K
Total Assets $33.35M $38.77M $25.06M
YoY Change -38.01% 54.71% -40.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $990.0K $1.080M $380.0K
YoY Change 148.23% 184.21% -50.84%
Accrued Expenses $1.600M $1.920M $960.0K
YoY Change 26.36% 100.0% 32.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.580M $2.990M $1.340M
YoY Change 54.95% 123.13% -10.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.580M $2.990M $1.340M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.580M $2.990M $1.340M
YoY Change 54.49% 123.13% -10.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $40.71K
YoY Change
Treasury Stock Shares 5.710K shares 5.710K shares 5.710K shares
Shareholders Equity $30.76M $35.78M $23.72M
YoY Change
Total Liabilities & Shareholders Equity $33.35M $38.77M $25.06M
YoY Change -38.01% 54.71% -40.48%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$5.760M -$7.009M -$2.956M
YoY Change 35.65% 137.14% -43.88%
Depreciation, Depletion And Amortization $10.00K $10.00K $0.00
YoY Change 0.0%
Cash From Operating Activities -$5.180M -$6.510M -$3.030M
YoY Change 34.2% 114.85% -13.18%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $39.20K $13.23K
YoY Change 196.31% 609.0%
Acquisitions
YoY Change
Other Investing Activities $3.460M $620.0K
YoY Change -122.87%
Cash From Investing Activities $3.440M $580.0K -$10.00K
YoY Change -122.74% -5900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 30.00K 140.0K
YoY Change -100.0% -78.57%
NET CHANGE
Cash From Operating Activities -5.180M -6.510M -3.030M
Cash From Investing Activities 3.440M 580.0K -10.00K
Cash From Financing Activities 0.000 30.00K 140.0K
Net Change In Cash -1.740M -5.900M -2.900M
YoY Change -112.86% 103.45% -16.91%
FREE CASH FLOW
Cash From Operating Activities -$5.180M -$6.510M -$3.030M
Capital Expenditures -$20.00K $39.20K $13.23K
Free Cash Flow -$5.160M -$6.549M -$3.043M
YoY Change 33.68% 115.21% -12.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32900 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2673391 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1055544 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4397013 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
2974239 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
7070404 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2974239 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7070404 USD
CY2015Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
18633 USD
CY2016Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
61659 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2955606 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7008745 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12819332 shares
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2955806 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35795 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-7009445 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6654 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
179042 USD
CY2015Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
400252 USD
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18251905 shares
CY2015Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
144536 USD
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
24375168 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2895 USD
CY2016Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
159839 USD
CY2016Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
24098383 USD
CY2016Q1 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
0 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6973650 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1918695 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-2955806 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
733502 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-43450 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81303 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4303 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
73252 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
570093 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-369479 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-968190 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3025238 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6509120 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13230 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39202 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13230 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
582064 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
136869 USD
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34249 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
136869 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
34249 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2901599 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5892807 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
15303 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0 USD
CY2016Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3178734 USD
CY2015Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
CY2015Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
0 USD
CY2016Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
35795 USD
CY2016Q1 us-gaap Accretion Expense
AccretionExpense
91566 USD
CY2015Q1 us-gaap Accretion Expense
AccretionExpense
0 USD
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3800000 USD
CY2015Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
24095488 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
24098383 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
0 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
0 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7009445 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7009445 USD
CY2013Q3 lpcn Percentage Of Fee To Be Received
PercentageOfFeeToBeReceived
0.2 pure
CY2013Q3 lpcn Service Fee
ServiceFee
230 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
63.96
CY2016Q1 lpcn Class Of Warrant Or Right Redemption Price Of Warrants Or Rights
ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
0.001
CY2016Q1 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2018-11-12
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
192000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22000 USD
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
729983 USD
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
283961 USD
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
387119 USD
CY2016Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
58903 USD
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
Lipocine Inc.
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001535955
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q1 dei Trading Symbol
TradingSymbol
LPCN
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18258901 shares
CY2016Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
700 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24966378 USD
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1067404 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1060750 USD
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18256901 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18250456 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18251191 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18244746 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2016Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
700 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2016Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24095488 USD
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9630 USD
CY2016Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6735 USD
CY2016Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
24098383 USD
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
24808320 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
594 USD
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
33494 USD
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
24775420 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
24095488 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24098383 USD
CY2016Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3800000 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24903325 USD
CY2016Q1 lpcn Description Of Terms Of Service Agreement
DescriptionOfTermsOfServiceAgreement
Under the service agreement, the Company provided facilities and up to 10 percent of the services of certain employees to Spriaso for a period of 18 months
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
733502 USD
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179042 USD
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0173 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8270 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.51
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
547000 shares
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20007659 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27666055 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14114852 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24764456 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
200 USD

Files In Submission

Name View Source Status
0001144204-16-099991-index-headers.html Edgar Link pending
0001144204-16-099991-index.html Edgar Link pending
0001144204-16-099991.txt Edgar Link pending
0001144204-16-099991-xbrl.zip Edgar Link pending
ex10-1_tpg25.jpg Edgar Link pending
ex10-1_tpg26.jpg Edgar Link pending
ex10-1_tpg27.jpg Edgar Link pending
ex10-1_tpg28.jpg Edgar Link pending
ex10-1_tpg29.jpg Edgar Link pending
ex10-1_tpg30.jpg Edgar Link pending
ex10-1_tpg31.jpg Edgar Link pending
ex10-1_tpg32.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lpcn-20160331.xml Edgar Link completed
lpcn-20160331.xsd Edgar Link pending
lpcn-20160331_cal.xml Edgar Link unprocessable
lpcn-20160331_def.xml Edgar Link unprocessable
lpcn-20160331_lab.xml Edgar Link unprocessable
lpcn-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v437924_10q.htm Edgar Link pending
v437924_ex10-1.htm Edgar Link pending
v437924_ex31-1.htm Edgar Link pending
v437924_ex31-2.htm Edgar Link pending
v437924_ex32-1.htm Edgar Link pending
v437924_ex32-2.htm Edgar Link pending